Clinical Trial Update: Atezolizumab and Bevacizumab With Photon Radiotherapy for Unresectable Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating atezolizumab and bevacizumab with photon radiotherapy for unresectable hepatocellular carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Avastin (bevacizumab)
• Tecentriq (atezolizumab)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: RECRUITING